Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 13/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 13/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | POLQ | O75417 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18137967 | 0.90 | SLC6A2 (0.56) | SLC6A2SLC6A4ACHEPOLQIDO1 | |
| SCHEMBL11473731 | 0.83 | CARM1 (0.53) | SLC6A2SLC6A4ACHEPOLQIDO1 | |
| SCHEMBL12124971 | 0.83 | SLC6A2 (0.54) | SLC6A2SLC6A4ACHEPOLQIDO1 | |
| SCHEMBL13965863 | 0.81 | SLC6A2 (0.50) | SLC6A2SLC6A4ACHEPOLQIDO1 | |
| SCHEMBL12831776 | 0.77 | SLC6A4 (0.50) | SLC6A2SLC6A4ACHEPOLQIDO1 | |
| SCHEMBL7132154 | 0.77 | CHRM2 (0.56) | ACHECHRM2KMT2A | |
| SCHEMBL13975072 | 0.76 | CHRM2 (0.47) | ACHECHRM2KMT2A | |
| SCHEMBL8723410 | 0.75 | CHRM2 (0.59) | ACHECHRM2KMT2A | |
| SCHEMBL8723370 | 0.75 | CHRM2 (0.59) | ACHECHRM2KMT2A | |
| SCHEMBL8720809 | 0.75 | CHRM2 (0.59) | ACHECHRM2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120295903-A1 | FLAVIN DERIVATIVES | BLOUNT KENNETH F (US) | 2012-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120295903-A1 | FLAVIN DERIVATIVES | BLVRB, FLAD1, FDPS | SLC6A2 2087/4885SLC6A4 1439/4885ACHE 3955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.